iShares MSCI France ETF vs BIO-TECHNE Corp — how do they compare? iShares MSCI France ETF trades at $45.16, while BIO-TECHNE Corp trades at $71.68 (market cap $11.14B). The key difference: BIO-TECHNE Corp pays a 0.45% dividend while iShares MSCI France ETF pays none, and BIO-TECHNE Corp is trading nearer its 52-week high, iShares MSCI France ETF nearer its low. Which is the better fit depends on your goals.
| EWQ | TECH | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $48.35 | $71.48 |
52-Week Low | $41.43 | $43.31 |
Market Cap | — | $11.14B |
Enterprise Value | — | $11.22B |
Dividend Yield | — | 0.45% |
Trailing returns across standard periods
Latest headlines on both assets
EWQ is a country-specific ETF that tracks the performance of the French equity market. It provides exposure to major global brands across sectors like luxury goods, industrials, and healthcare, including LVMH, Schneider Electric, and Hermes.
Read more on EWQ →Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →